TSX:ONC 0.79 CAD +0.00 +0% Volume: 37,250 July 29, 2015
NASDAQ:ONCY 0.61 USD +0.01 +2% Volume: 254,730 July 29, 2015

For Investors

The Cutting Edge of Cancer Innovation

Oncolytics Biotech Inc. is a developer of oncolytic viruses as cancer therapeutics and is listed on the Toronto Stock Exchange (TSX:ONC) and the NASDAQ (NASDAQ:ONCY). In addition to the information available on this site, investors can access the Company’s regulatory filings on the SEDAR website at www.sedar.com and on the EDGAR website at www.sec.gov.


Access our quarterly and year-end financial statements, MD&A, information circulars and annual reports.

View Financials

Stock Information

View our stock charts and other information about our stock (TSX:ONC, NASDAQ:ONCY).

View Stock Information

Analyst Coverage

Find out which analysts and institutions provide coverage of Oncolytics.

View Analyst Coverage

Investor Presentation

Click here to load our most recent investor presentation.

View Presentation

Latest News

July 06, 2015 Oncolytics Biotech® Inc. Collaborators Present Final Data from REO 017 Clinical Study in Pancreatic Cancer
June 15, 2015 Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Data at the 9th International Conference on Oncolytic Virus Therapeutics
June 12, 2015 Oncolytics Biotech® Inc. Announces Voting Results from its Annual Meeting of Shareholders
Sign up to receive e-mail updates *